Congress Materials

Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Oral Presentation
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM October 20, 2022 IDWEEK 2022 Coronovirus Disease

Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

View Presentation
Poster
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Harrington MA, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM October 21, 2022 IDWEEK 2022 Coronovirus Disease

Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo

View Presentation
Poster
Ansari W, Draica F, Atkinson J, Annunziata K, Maculaitis MC, Scott A October 21, 2022 IDWEEK 2022 Coronovirus Disease

Understanding the Psychosocial Burden Associated with Hospitalization Among Adults Diagnosed with COVID-19 in the United States

View Presentation
Poster
Jongihlati B, Segall N, Block SL, Peterson JT, Absalon J, Munson S, Sanchez-Pearson Y, Simon R, Silmon de Monerri NC, Radley D, Gomme E, Gaylord M, Gruber WC, Jansen KU, Scott DA, Anderson AS October 23, 2022 IDWEEK 2022 Group B Streptococcus

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6)

View Presentation
Poster
Paradowska-Stankiewicz I, Zbrzeźniak J, Skufca J, Nagarajan A, Ochocka P, Pilz A, Vyse A, Begier E, Dzingina M, Blum, M Riera-Monte Ms, Gessner BD, Stark JH October 23, 2022 IDWEEK 2022 Lyme Disease

A retrospective database study of Lyme borreliosis incidence and distribution in Poland from 2015 to 2019

View Presentation
Poster
Ramirez JA, Carrico R, Wilde A, Junkins A, Furmanek S, Chandler T, Schulz P, Hubler R, Peyrani P, Trivedi S, Liu Q, Uppal S, Gessner B, Begier E, and the NIDI RSV Study Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection

View Presentation
Poster
Huang L, Cane A, Perdrizet J, Arguedas A October 23, 2022 IDWEEK 2022 Pneumococcal Disease

Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States

View Presentation
Oral Presentation
Walsh E, Polack F, Zareba AM, Falsey A, Marc GP, Jiang Q, Schneider K, Cooper D, Lino MM, Anderson A, Jansen KU, Swanson K, Gurtman A, Gruber W, Schmoele-Thoma B for the RENOIR Clinical Trial Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Efficacy and Safety of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine in Older Adults

View Presentation
Oral Presentation
Simões EAF, Madhi S, Paeds. F.C., Center KJ, Llapur C, Pizarro JN, Swanson KA, Radley D, McGrory SB, Gomme E, Scott DA, Jansen KU, Gruber WC, Gurtman AC October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

View Presentation
Poster
Skufca J, De Smedt N, Pilz A, Vyse A, Begier E, Blum M, Riera M, Gessner B, Stark JH October 23, 2022 IDWEEK 2022 Lyme Disease

Exploring spatial and temporal trends in the incidence of Lyme borreliosis in Finland using surveillance data, 2015 -2020

View Presentation